Michelle L Katz1, Craig R Kollman2, Carly E Dougher3, Mohamed Mubasher2, Lori M B Laffel3. 1. Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA michelle.katz@joslin.harvard.edu. 2. Jaeb Center for Health Research, Tampa, FL. 3. Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA.
Abstract
OBJECTIVE: To assess the influence of HbA1c and BMI (measured as BMI z score [zBMI]) on LDL, HDL, and non-HDL trajectories as youths with type 1 diabetes age into early adulthood. RESEARCH DESIGN AND METHODS: Dynamic, retrospective cohort study examining changes in lipid values in 572 youths with type 1 diabetes followed longitudinally for a median of 9.3 years. Through longitudinal modeling, we describe the relationship of HbA1c and zBMI on lipid values as subjects age after adjusting for other relevant factors, including lipid-lowering medication use. RESULTS: The median number of lipid assessments was 7 (range 2-39). Every 1% increase in HbA1c was associated with an ∼2-6 mg/dL increase in LDL levels, with a greater increase in LDL levels as subjects progressed from prepubertal to postpubertal age ranges. A 1-SD increase in BMI was associated with a mean LDL increase of 2.1 mg/dL when subjects were 10 years old and increased to a mean of 8.2 mg/dL when subjects were 19 years old. The association between changes in HbA1c level and zBMI and changes in non-HDL levels as youths aged were similar to the associations found with LDL. The influence of HbA1c and zBMI on HDL levels was small and not dependent on age. CONCLUSIONS: Changes in HbA1c level and zBMI modestly impact LDL and non-HDL cholesterol and have greater impacts as children age. Addressing elevations in HbA1c and zBMI as children enter into adolescence and beyond may lead to improvements in lipid levels.
OBJECTIVE: To assess the influence of HbA1c and BMI (measured as BMI z score [zBMI]) on LDL, HDL, and non-HDL trajectories as youths with type 1 diabetes age into early adulthood. RESEARCH DESIGN AND METHODS: Dynamic, retrospective cohort study examining changes in lipid values in 572 youths with type 1 diabetes followed longitudinally for a median of 9.3 years. Through longitudinal modeling, we describe the relationship of HbA1c and zBMI on lipid values as subjects age after adjusting for other relevant factors, including lipid-lowering medication use. RESULTS: The median number of lipid assessments was 7 (range 2-39). Every 1% increase in HbA1c was associated with an ∼2-6 mg/dL increase in LDL levels, with a greater increase in LDL levels as subjects progressed from prepubertal to postpubertal age ranges. A 1-SD increase in BMI was associated with a mean LDL increase of 2.1 mg/dL when subjects were 10 years old and increased to a mean of 8.2 mg/dL when subjects were 19 years old. The association between changes in HbA1c level and zBMI and changes in non-HDL levels as youths aged were similar to the associations found with LDL. The influence of HbA1c and zBMI on HDL levels was small and not dependent on age. CONCLUSIONS: Changes in HbA1c level and zBMI modestly impact LDL and non-HDL cholesterol and have greater impacts as children age. Addressing elevations in HbA1c and zBMI as children enter into adolescence and beyond may lead to improvements in lipid levels.
Authors: Lori M B Laffel; Laura Vangsness; Alexa Connell; Ann Goebel-Fabbri; Deborah Butler; Barbara J Anderson Journal: J Pediatr Date: 2003-04 Impact factor: 4.406
Authors: David M Maahs; R Paul Wadwa; Kim McFann; Kristen Nadeau; Matthew R Williams; Robert H Eckel; Georgeanna J Klingensmith Journal: J Pediatr Date: 2007-02 Impact factor: 4.406
Authors: Michelle L Katz; Lisa K Volkening; Deborah A Butler; Barbara J Anderson; Lori M Laffel Journal: Pediatr Diabetes Date: 2013-08-05 Impact factor: 4.866
Authors: A S Krolewski; E J Kosinski; J H Warram; O S Leland; E J Busick; A C Asmal; L I Rand; A R Christlieb; R F Bradley; C R Kahn Journal: Am J Cardiol Date: 1987-04-01 Impact factor: 2.778
Authors: David M Maahs; Dana Dabelea; Ralph B D'Agostino; Jeannette S Andrews; Amy S Shah; Nancy Crimmins; Elizabeth J Mayer-Davis; Santica Marcovina; Giuseppina Imperatore; R Paul Wadwa; Steven R Daniels; Kristi Reynolds; Richard F Hamman; Lawrence M Dolan Journal: J Pediatr Date: 2012-07-11 Impact factor: 4.406
Authors: Benjamin Udoka Nwosu; Tony R Villalobos-Ortiz; Gabrielle A Jasmin; Sadichchha Parajuli; Emily Zitek-Morrison; Bruce A Barton Journal: J Pediatr Endocrinol Metab Date: 2020-11-26 Impact factor: 1.520
Authors: Jane L Chiang; David M Maahs; Katharine C Garvey; Korey K Hood; Lori M Laffel; Stuart A Weinzimer; Joseph I Wolfsdorf; Desmond Schatz Journal: Diabetes Care Date: 2018-08-09 Impact factor: 19.112
Authors: Benjamin Udoka Nwosu; Shwetha Rupendu; Emily Zitek-Morrison; Deepa Patel; Tony R Villalobos-Ortiz; Gabrielle Jasmin; Bruce A Barton Journal: J Endocr Soc Date: 2019-02-27
Authors: Benjamin Udoka Nwosu; Bo Zhang; Sanaa S Ayyoub; Stephanie Choi; Tony R Villalobos-Ortiz; Laura C Alonso; Bruce A Barton Journal: PLoS One Date: 2018-05-16 Impact factor: 3.240